Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Companies Develop More “Cost-Effective” Non-Fish Omega-3 Products

This article was originally published in The Tan Sheet

Executive Summary

Industry demand for cost-effective omega-3 oils for food and beverage applications has led several companies to start innovative research and development of non-fish-derived oils

You may also be interested in...



Omega-3 Global Organization

Vendors launch trade group for increasing regulatory approvals for EPA- and DHA-based products, developing education strategies and consumer awareness and implementing quality standards that will protect omega-3 EPA/DHA brands at Natural Products Expo East in Baltimore Oct. 4-7. The Global Organization for EPA & DHA Omega-3 (GOED Omega-3) includes processors, refiners, manufacturers, distributors, marketers and retailers as well as healthcare professionals, educators and researchers. GOED Omega-3 will take on a broader mandate than CRN's now-dissolved Omega-3 Working Group, but will also build on its accomplishments, including product-quality focus and industry acceptance of the voluntary Omega-3 monograph, the group says. GOED Omega-3's start-up committee includes Robert Orr, president and CEO of Ocean Nutrition Canada; Philip Fass, vice president of sales/marketing at Martek Biosciences; Bjorn Rene, vice president of sales at Napro Pharma; and Ian Newton, president of Ceres Consulting...

OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study

Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers

OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study

Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers

Topics

UsernamePublicRestriction

Register

LL1134025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel